Reduced O Glycosylation of Sp1 Is Associated with Increased Proteasome Susceptibility

REFERENCES

• Aristarkhow, A., E. Eytan, A. Moghe, A. Admon, A. Hershko, and J. V. Ruderman. 1996. E2-C, a cyclin-selective ubiquitin carrier protein required for the destruction of mitotic cyclins. Proc. Natl. Acad. Sci. USA 93:4294–4299.
   PubMedGoogle Scholar
• Azizkhan, J. C., D. E. Jensen, A. J. Pierce, and M. Wade. 1993. Transcription from TATA-less promoters: dihydrofolate reductase as a model. Crit. Rev. Eukaryot. Gene Expression 3:229–254.
   PubMedGoogle Scholar
• Barral, Y., S. Jentsch, and C. Mann. 1995. G1 cyclin turnover and nutrient uptake are controlled by a common pathway in yeast. Genes Dev. 9:399–409.
   PubMedGoogle Scholar
• Biggs, J. R., J. E. Kudlow, and A. S. Kraft. 1996. The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 leukemic cells. J. Biol. Chem. 271:901–906.
   PubMed Web of Science ®Google Scholar
• Briggs, M. R., J. T. Kadonaga, S. P. Bell, and R. Tjian. 1986. Purification and biochemical characterization of the promoter specific transcription factor Sp1. Science 234:47–52.
   PubMed Web of Science ®Google Scholar
• Chakraborty, A., D. Saha, A. Bose, M. Chatterjee, and N. K. Gupta. 1994. Regulation of eIF-2 α-subunit phosphorylation in reticulocyte lysate. Biochemistry 33:6700–6706.
   PubMed Web of Science ®Google Scholar
• Chen, L. I., T. Nishinaka, K. Kwan, I. Kitabayashi, K. Yokoyama, Y. H. F. Fu, S. Grunwald, and R. Chiu. 1994. The retinoblastoma gene product RB stimulates Sp1-mediated transcription by liberating Sp1 from a negative regulator. Mol. Cell. Biol. 14:4380–4389.
   PubMed Web of Science ®Google Scholar
• Chou, T.-Y., C. V. Dang, and G. W. Hart. 1995. Glycosylation of the c-Myc transactivation domain. Proc. Natl. Acad. Sci. USA 92:4417–4421.
   PubMedGoogle Scholar
• Chou, T. Y., G. W. Hart, and C. V. Dang. 1995. c-Myc is glycosylated at threonine 58, a known phosphorylation site and a mutational hot spot in lymphomas. J. Biol. Chem. 270:18961–18965.
   PubMed Web of Science ®Google Scholar
• Ciechanover, A. 1994. The ubiquitin-proteosome proteolytic pathway. Cell 79:13–21.
   PubMed Web of Science ®Google Scholar
• Cook, S. J., and F. McCormick. 1993. Inhibition by cAMP of Ras-dependent activation of Raf. Science 262:1069–1072.
   PubMed Web of Science ®Google Scholar
• Daniels, M. C., P. Kansal, T. Smith, A. J. Paterson, J. E. Kudlow, and D. A. McClain. 1993. Glucose regulation of transforming growth factor-a expression mediated by products of hexosamine biosynthesis pathway. Mol. Endocrinol. 7:1041–1048.
   PubMed Web of Science ®Google Scholar
• Datta, B., D. Chakrabarti, A. L. Roy, and N. K. Gupta. 1988. Roles of a 67-kDa polypeptide in reversal of protein synthesis inhibition in heme-deficient reticulocyte lysate. Proc. Natl. Acad. Sci. USA 85:3324–3328.
   PubMed Web of Science ®Google Scholar
• Datta, B., M. Ray, D. Chakrabarti, D. E. Wylie, and N. K. Gupta. 1989. Glycosylation of eukaryotic peptide chain initiation factor 2 (eIF-2)-associ-ated 67-kDa polypeptide (P67) and its possible role in the inhibition of eIF-2 kinase-catalyzed phosphorylation of the eIF-2 α-subunit. J. Biol. Chem. 264:20620–20624.
   PubMedGoogle Scholar
• Deshaies, R. J., V. Chau, and M. Kirschner. 1995. Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway. EMBO J. 14:303–312.
   PubMedGoogle Scholar
• The Diabetes Control and Complications Trial Research Group. 1993. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N. Engl. J. Med. 329:977–986.
   PubMed Web of Science ®Google Scholar
• Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475–1489.
   PubMed Web of Science ®Google Scholar
• Dynan, W. S., J. D. Saffer, W. S. Lee, and R. Tjian. 1985. Transcription factor Sp1 recognizes promoter sequences from the monkey genome that are similar to the simian virus 40 promoter. Proc. Natl. Acad. Sci. USA 82:4915–4919.
   PubMedGoogle Scholar
• Elias, S., B. Bercovich, C. Kahana, P. Coffino, M. Fischer, W. Hilt, D. H. Wolf, and A. Ciechanover. 1995. Degradation of ornithine decarboxylase by the mammalian and yeast 26S proteasome complexes requires all the components of the protease. Eur. J. Biochem. 229:276–283.
   PubMedGoogle Scholar
• Fenteany, G., R. R. Standaert, W. S. Lane, S. Choi, E. J. Corey, and S. L. Schreiber. 1995. Inhibition of proteasome activities and subunit-specific ami-no-terminal threonine modification by lactacystin. Science 268:726–731.
   PubMed Web of Science ®Google Scholar
• Han, I.-O., and J. E. Kudlow. Domain specific interaction between transcription factor Sp1 and nuclear pore protein p62. Submitted for publication.
   Google Scholar
• Hochstrasser, M. 1996. Protein degradation or regulation: Ub the judge. Cell 84:813–815.
   PubMed Web of Science ®Google Scholar
• Horowitz, J. M., D. W. Yandell, S.-H. Park, S. Canning, P. Whyte, K. J. Buchovich, E. Harlow, R. A. Weinberg, and T. P. Dryja. 1989. Point mutational inactivation of the retinoblastoma antioncogene. Science 243:937–940.
   PubMed Web of Science ®Google Scholar
• Ishii, H., M. R. Jirousek, D. Koya, C. Takagi, P. Xia, A. Clermont, S. E. Bursell, T. S. Kern, L. M. Ballas, W. F. Heath, L. E. Stramm, E. P. Feener, and G. L. King. 1996. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science 272:728–731.
   PubMed Web of Science ®Google Scholar
• Jackson, S. P., J. J. MacDonald, S. Lees-Miller, and R. Tjian. 1990. GC-box binding induces phosphorylation of Sp1 by a DNA-dependent protein ki-nase. Cell 63:155–165.
   PubMed Web of Science ®Google Scholar
• Jackson, S. P., and R. Tjian. 1988. O-glycosylation of eukaryotic transcription factors: implications for mechanism of transcriptional regulation. Cell 55:125–133.
   PubMed Web of Science ®Google Scholar
• Jariel-Encoutre, I., M. Patriat, F. Martin, S. Carillo, C. Salvat, and M. Piechaczyk. 1995. Ubiquitination is not an absolute requirement for degradation of c-Jun protein by the 26 S proteasome. J. Biol. Chem. 270:11623–11627.
   PubMedGoogle Scholar
• Kadonaga, J. T., K. R. Carner, F. R. Masiarz, and R. Tjian. 1987. Isolation of cDNA encoding transcription factor Sp1 and functional analysis of the DNA binding domain. Cell 51:1079–1090.
   PubMed Web of Science ®Google Scholar
• Kadonaga, J. T., K. A. Jones, and R. Tjian. 1986. Promoter specific activation of RNA polymerase II by Sp1. Trends Biochem. Sci. 11:20–23.
   Web of Science ®Google Scholar
• Kato, J. Y., M. Matsuoka, K. Polyak, J. Massague, and C. J. Sherr. 1994. Cyclic AMP-induced G1 phase arrest mediated by an inhibitor (p27Kip1) of cyclin-dependent kinase 4 activation. Cell 79:487–496.
   PubMed Web of Science ®Google Scholar
• Kelly, W. G., M. E. Dahmus, and G. W. Hart. 1993. RNA polymerase II is a glycoprotein: modification of the C-terminal domain by O-GlcNAc. J. Biol. Chem. 268:10416–10424.
   PubMed Web of Science ®Google Scholar
• Lubas, W. A., M. Smith, C. M. Starr, and J. A. Hanover. 1995. Analysis of nuclear pore protein p62 glycosylation. Biochemistry 34:1686–1694.
   PubMed Web of Science ®Google Scholar
• McClain, D. A., A. J. Paterson, M. D. Roos, X. Wei, and J. E. Kudlow. 1992. Glucose and glucosamine regulate growth factor gene expression in vascular smooth muscle cells. Proc. Natl. Acad. Sci. USA 89:8150–8154.
   PubMedGoogle Scholar
• Measday, V., L. Moore, J. Ogas, M. Tyers, and B. Andrews. 1994. The PCL2 (ORFD)-Pho85 cyclin-dependent protein kinase complex: a cell cycle regulator in yeast. Science 266:1391–1395.
   PubMedGoogle Scholar
• Moss, B. 1991. Vaccinia virus: a tool for research and vaccine development. Science 252:1662–1667.
   PubMed Web of Science ®Google Scholar
• Pugh, B. F., and R. Tjian. 1991. Transcription from a TATA-less promoter requires a multi-subunit TFIID complex. Genes Dev. 5:1935–1945.
   PubMedGoogle Scholar
• Reason, A. J., H. R. Morris, M. Panico, R. Marais, R. H. Treisman, R. S. Haltiwanger, G. W. Hart, W. G. Kelly, and A. Dell. 1992. Localization of O-GlcNAc modification on the serum response transcription factor. J. Biol. Chem. 267:16911–16921.
   PubMed Web of Science ®Google Scholar
• Richter-Ruoff, B., and D. H. Wolf. 1993. Proteasome and cell cycle. Evidence for a regulatory role of the protease on mitotic cyclins in yeast. FEBS Lett. 336:34–36.
   PubMedGoogle Scholar
• Roberts, A. B., M. A. Anzano, L. M. Wakefield, N. S. Roche, D. F. Stern, and M. B. Sporn. 1985. Type beta transforming growth factor: a bifunctional regulator of cellular growth. Proc. Natl. Acad. Sci. USA 82:119–123.
   PubMed Web of Science ®Google Scholar
• Roos, M. D., I. O. Han, A. J. Paterson, and J. E. Kudlow. 1996. Role of glucosamine synthesis in the stimulation of TGF-a gene transcription by glucose and EGF. Am. J. Physiol. 270:C803–C811.
   PubMedGoogle Scholar
• Roos, M. D., and J. E. Kudlow. Unpublished results.
   Google Scholar
• Ross, R. 1993. The pathogenesis of atherosclerosis: a perspective for 1990s. Nature 362:801–809.
   PubMed Web of Science ®Google Scholar
• Saffer, J. D., S. P. Jackson, and M. B. Annarella. 1991. Developmental expression of Sp1 in the mouse. Mol. Cell. Biol. 11:2189–2199.
   PubMed Web of Science ®Google Scholar
• Saffer, J. D., S. P. Jackson, and S. J. Thurston. 1990. SV40 stimulates expression of the transacting factor Sp1 at the mRNA level. Genes Dev. 4:659–666.
   PubMedGoogle Scholar
• Santos, R. C., N. C. Waters, C. L. Creasy, and L. W. Bergman. 1995. Structure-function relationships of the yeast cyclin-dependent kinase Pho85. Mol. Cell. Biol. 15:5482–5491.
   PubMedGoogle Scholar
• Sayeski, P. P., and J. E. Kudlow. 1996. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-a gene transcription. J. Biol. Chem. 271:15237–15243.
   PubMed Web of Science ®Google Scholar
• Seamon, K. B., and J. W. Daly. 1981. Forskolin: a unique diterpene activator of cyclic AMP-generating systems. J. Cyclic Nucleotide Res. 7:201–224.
   PubMedGoogle Scholar
• Shin, T. H., A. J. Paterson, J. H. Grant III, A. A. Meluch, and J. E. Kudlow. 1992. 5-Azacytidine treatment of HA-A melanoma cells induces Sp1 activity and concomitant transforming growth factor a expression. Mol. Cell. Biol. 12:3998–4006.
   PubMedGoogle Scholar
• Snow, C. M., A. Senior, and L. Gerace. 1987. Monoclonal antibodies identify a group of nuclear pore complex proteins. J. Cell Biol. 104:1143–1156.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1995. The retinoblastoma protein and cell cycle control. Cell 81:323–330.
   PubMed Web of Science ®Google Scholar
• Wu, J., P. Dent, T. Jelinek, A. Wolfman, M. J. Weber, and T. W. Sturgill. 1993. Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065–1069.
   PubMed Web of Science ®Google Scholar
• Yaglom, J., M. H. Linskens, S. Sadis, D. M. Rubin, B. Futcher, and D. Finley. 1995. p34Cdc28-mediated control of Cln3 cyclin degradation. Mol. Cell. Biol. 15:731–741.
   PubMedGoogle Scholar